Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies [Phase 1]
This update covers a Phase 1 study of satraplatin in combination with capecitabine for advanced solid malignancies, sponsored by Agennix; th…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors [Phase 1]
Phase I study of intravenous Lipotecan (TLC388 HCl) in patients with advanced solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2012-01-27Clinical Trial Update: A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial studied how radiolabeled eribulin is metabolized and eliminated in patients with advanced solid tumors; results were post…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: CP-868,596 And CP-868,596 Plus AG-013736 In Combination With Docetaxel In Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating CP-868,596 alone and in combination with AG-013736 and docetaxel in patients with solid tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Clinical Trial to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of Oral Paclitaxel in Patients With Advanced Solid Cancer [Phase 1]
Phase 1 study evaluating the maximum tolerated dose, safety, and pharmacokinetics of oral paclitaxel in patients with advanced solid tumors;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors [Phase 1]
Phase 1 study of MEDI-547 in relapsed or refractory solid tumors was terminated; the update provides information on safety, tolerability, an…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors [Phase 2]
This Phase 2 study update assesses the safety and effectiveness of Combretastatin A-4 Phosphate in combination with chemotherapy for advance…
-
CLINICAL_TRIALS trial_result · 2011-10-31Clinical Trial Update: Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 safety study evaluating escalating doses of combretastatin in combination with bevacizumab (Avastin) in patients with advanced sol…
-
CLINICAL_TRIALS trial_result · 2011-10-19Clinical Trial Update: Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of ARQ 621 in adults with metastatic solid tumors and refractory/relapsed hematologic malignancies has complet…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: A Study to Evaluate Biomarkers in Patients With Solid Tumors (0000-097)(COMPLETED) [Phase 1]
A Phase 1 trial evaluating biomarkers in patients with solid tumors has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-24Clinical Trial Update: Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement [Phase 1]
A completed Phase 1 dose-escalation study evaluating intravenous ALN-VSP02 in patients with advanced solid tumors involving the liver, asses…
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors [Phase 1]
An update on a Phase 1 study of liposome-encapsulated docetaxel (LE-DT) in patients with solid tumors, with the trial status marked as compl…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy [Phase 1]
This trial update reports the completion of a Phase 1 study evaluating the combination of Alvespimycin (KOS-1022) with trastuzumab, with or …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Evaluation of KX2-391 in Patients With Advanced Malignancies [Phase 1]
This entry reports completion of a Phase 1 trial evaluating KX2-391 in patients with advanced solid tumors and lymphoma.
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial update of plitidepsin in combination with sorafenib or gemcitabine in patients with advanced solid tumors or lymphoma…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: 10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies [Phase 1]
Phase 1 pharmacokinetic study of ZD4054 (Zibotentan) in elderly Chinese men with advanced solid tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update evaluating a combination of pemetrexed and oxaliplatin in patients with metastatic solid tumors or lymphoma; the study …
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours [Phase 1]
Phase 1 study assessing how ketoconazole affects the pharmacokinetics of cediranib in patients with solid tumors to evaluate potential drug-…
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation for solid tumors and hematologic neoplasms; the curre…
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan [Phase 1]
Phase 1 multiple ascending dose study of BMS-907351 (XL184) in Japanese patients with solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-05Clinical Trial Update: Safety of CHIR-258 (TKI258) in Advanced Solid Tumors [Phase 1]
This notice summarizes safety data from a Phase 1 study of CHIR-258 (TKI-258) in patients with advanced solid tumors. The trial status is te…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax). [Phase 1]
Phase 1 study evaluating how ketoconazole affects the metabolism of navitoclax (ABT-263) in patients with lymphoma, chronic lymphocytic leuk…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 dose-escalation and pharmacokinetics study of the investigational drug M2ES in subjects with solid tumors.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer [Phase 1]
Phase 1 study evaluating how rifampin affects the pharmacokinetics of ixabepilone in patients with advanced cancer.
-
CLINICAL_TRIALS trial_result · 2010-09-30Clinical Trial Update: Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy [Phase 1]
A completed Phase 1 safety study evaluating IMC-18F1 in patients with advanced solid tumors that no longer respond to standard therapy.